Literature DB >> 33778677

Combination of Chemoembolization plus Radiofrequency Ablation May Provide Better Survival Outcomes than Monotherapy for HCC.

Luke R Wilkins.   

Abstract

Mesh：

Year:  2019        PMID： 33778677      PMCID： PMC7983659          DOI： 10.1148/rycan.2019194005

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN： 2638-616X


× No keyword cloud information.
  1 in total

1.  Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis.

Authors:  Hee Ho Chu; Jin Hyoung Kim; Hyun-Ki Yoon; Heung-Kyu Ko; Dong Il Gwon; Pyo Nyun Kim; Kyu-Bo Sung; Gi-Young Ko; So Yeon Kim; Seong Ho Park
Journal:  J Vasc Interv Radiol       Date:  2019-08-27       Impact factor: 3.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.